MAVYRET 100-40 MG TABLET

Glecaprevir and Pibrentasvir

$152.8340per EA

Strength

100; 40 mg/1; mg/1

Manufacturer

AbbVie Inc.

NDC

00074262528

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

GLECAPREVIR; PIBRENTASVIR

Approval Type

New Drug (NDA)

FDA Application

NDA209394

On Market Since

8/3/2017

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors

Cytochrome P450 1A2 Inhibitors

Cytochrome P450 3A Inhibitors

HCV NS3/4A Protease Inhibitors

Hepatitis C Virus NS3/4A Protease Inhibitor

Hepatitis C Virus NS5A Inhibitor

Organic Anion Transporting Polypeptide 1B1 Inhibitors

Organic Anion Transporting Polypeptide 1B3 Inhibitors

P-Glycoprotein Inhibitors

UGT1A1 Inhibitors

Price History

1W

0.0%

1M

-0.0%

3M

-0.1%

6M

+0.0%

1Y

+0.0%

3Y

+0.0%

5Y

-0.2%

All

-0.3%

Generic Alternatives

1 alternative • Same active ingredient

MAVYRET 100-40 MG TABLET

Brand

00074262504•AbbVie Inc.

$152.8336

Related Drugs

Same classification

MYRBETRIQ ER 8 MG/ML SUSP

Brand

00469502099•Astellas Pharma US, Inc.

$2.2097

per ML

ZONISADE 100 MG/5 ML ORAL SUSP

Brand

52652800101•Azurity Pharmaceuticals Inc.

$2.7530

per ML

NEORAL 25 MG GELATIN CAPSULE

Brand

00078024615•Novartis Pharmaceuticals Corporation

$2.8879

per EA

KALETRA 80 MG-20 MG/ML SOLN

Brand

00074395646•AbbVie Inc.

$3.1186

per ML

KATERZIA 1 MG/ML SUSPENSION

Brand

52652500101•Azurity Pharmaceuticals Inc.

$4.1914

per ML

SANDIMMUNE 25 MG CAPSULE

Brand

00078024015•Novartis Pharmaceuticals Corporation

$4.3773

per EA

BRILINTA 90 MG TABLET

Brand

00186077739•AstraZeneca Pharmaceuticals LP

$7.4222

per EA

BRILINTA 90 MG TABLET

Brand

00186077760•AstraZeneca Pharmaceuticals LP

$7.4222

per EA

BRILINTA 60 MG TABLET

Brand

00186077660•AstraZeneca Pharmaceuticals LP

$7.4281

per EA

KALETRA 200-50 MG TABLET

Brand

00074401412•AbbVie Inc.

$8.3041

per EA